PharmaShots Weekly Snapshot (September 09 - 13, 2019)
Published: Sept 13, 2019 | Tags: Eisai, Biogen, Terminate Two, P-III, Clinical Studies, Elenbecestat, E2609, Early Alzheimer's Disease
2. GE Healthcare's Critical Care Suite AI-Powered X-ray Device Receives FDA's 510(k) Clearance to Identify Pneumothorax
Published: Sept 12, 2019 | Tags: GE Healthcare, Critical Care Suite, AI-Powered, X-ray Device, Receives, FDA, 510(k) Clearance, Identify, Pneumothorax
Published: Sept 13, 2019 | Tags: Celgene, Reports, Results, CC-486, P-III, QUAZAR AML-001, Maintenance Therapy, Acute Myeloid Leukemia
Published: Sept 12, 2019 | Tags: GSK, Nucala, mepolizumab, Receives, US, FDA, Approval, First Biologic, Severe Eosinophilic Asthma, Children, Aged 6-11yrs.
5.Roche Reports Results of Perjeta (pertuzumab) Fixed Dose SC Combination Therapy in P-III FeDeriCa Study for HER2+ve Breast Cancer
Published: Sept 13, 2019 | Tags: Roche, Reports, Results, Fixed Dose, SC, Combination Therapy, P-III, FeDeriCa Study, HER2-positive Breast Cancer
6. Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M
Published: Sept 12, 2019 | Tags: Aytu BioScience, Acquire, Innovus Pharmaceuticals, ~$24M
Published: Sept 12, 2019 | Tags: Vertex, Enters, Access Agreement, Scottish Government, Orkambi, lumacaftor/ivacaftor, Symkevi, tezacaftor/ivacaftor
8.Hansoh Enters into a Collaboration with Atomwise for AI-Based Drug Discovery
Published: Sept 11, 2019 | Tags: Hansoh, Enters, Collaboration, Atomwise, AI, Drug Discovery, $1.5B
Published: Sept 11, 2019 | Tags: Janssen, Reports, Results, Ponesimod, P-III, OPTIMUM, Study, Relapsing, Multiple Sclerosis, Adults
10.Zentiva to Acquire Sanofi's Ankleshwar Manufacturing Facility in India
Published: Sept 11, 2019 | Tags: Zentiva, Acquire, Sanofi, Manufacturing Facility, Ankleshwar, India
Published: Sept 12, 2019 | Tags: ¬Roche, Reports, Results, Satralizumab, Second, P-III, Study, Neuromyelitis Optica Spectrum Disorder
12. Teva Canada's Herzuma (biosimilar, trastuzumab) Receives Health Canada Approval for Multiple Cancer Indications
Published: Sept 11, 2019 | Tags: ¬Teva Canada, Herzuma, biosimilar, trastuzumab, Receives, Health Canada, Approval, Multiple Cancer Indications
13. GSK to Acquire Sitari Pharmaceuticals for its Celiac Diseases Program
Published: Sept 11, 2019 | Tags: ¬GSK, Acquire, Sitari Pharmaceuticals, Celiac Diseases Program
14. Apple to Launch a Research App for Three Medical Studies Monitoring Health Issues
Published: Sept 10, 2019 | Tags: Apple, Launch, Research App, Three, Medical Studies, Monitoring, Health Issues
Published: Sept 11, 2019 | Tags: Merck KGaA, Tepotinib, Receives, FDA, Breakthrough Therapy Designation, Metastatic, NSCLC, METex14 Skipping Alterations
16. Samsung Bioepis Reports the Availability of Brenzys (biosimilar, etanercept) in Brazil
Published: Sept 10, 2019 | Tags: Samsung Bioepis, Reports, Availability, Brenzys, biosimilar, etanercept, Brazil
17.Google Collaborates with Mayo Clinic for Healthcare Innovation Utilizing AI and Cloud Computing
Published: Sept 10, 2019 | Tags: Google, Collaborates, Mayo Clinic, Healthcare Innovation, AI, Cloud Computing
Published: Sept 10, 2019 | Tags: Xeris, GVOKE, glucagon, Receives, FDA, Approval, Ready-To-Use Stable Liquid Glucagon, Severe Hypoglycemia
19.Sanofi Terminates its Four Years Alliance with Lexicon for Zynquista (sotagliflozin)
Published: Sept 10, 2019 | Tags: Sanofi, Terminates, Four Years, Alliance, Settlement, Lexicon, Zynquista, sotagliflozin
20. Baxter to Acquire Cheetah Medical for ~$230M
Published: Sept 10, 2019 | Tags: Baxter, Acquire, Cheetah Medical, ~$230M
21.Mallinckrodt to Divest its Subsidiary BioVectra for $250M
Published: Sept 10, 2019 | Tags: Mallinckrodt, Divest, Subsidiary, BioVectra, $250M
22.BMS Reports Pooled Five Year Results of Opdivo (nivolumab) in Two P-III Studies for Advanced Non-Small Cell Lung Cancer
Published: Sept 10, 2019 | Tags: BMS, Reports, Pooled Five Year, Results, Opdivo, nivolumab, Two, P-III, Studies, Advanced, Non-Small Cell Lung Cancer23
Published: Sept 10, 2019 | Tags: Alexion, Enters, Exclusive, License Agreement, Eidos, Develop, Commercialize, AG10, Japan
24.Genmab Signs an Agreement with Tempus to Develop Novel Targets and Biomarkers for Cancer Indications
Published: Sept 09, 2019 | Tags: Genmab, Signs, Agreement, Tempus, Develop, Novel Targets, Biomarkers, Cancer Indications
25.Medtronic's MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany
Published: Sept 09, 2019 | Tags: Medtronic, MiniMed 670G Insulin Pump System, Receives, Reimbursement, Germany
Published: Sept 09, 2019 | Tags: Allergan, Molecular Partners, Report, Acceptance, FDA, BLA, Validation, EMA, MAA, Abicipar Pegol
Published: Sept 05, 2019 | Tags: Abbott, World, First, Study, Evaluate, TriClip Transcatheter Tricuspid Valve Repair System, US
Published: Sept 09, 2019 | Tags: AstraZeneca, Reports, Results, Imfinzi, durvalumab, P-III, CASPIAN Study, 1L, Extensive-Stage Small Cell Lung Cancer
29. Eli Lilly Signs an Agreement with Thermo Fisher to Develop CDx for its Selpercatinib (LOXO-292)
Published: Sept 09, 2019 | Tags: Eli Lilly, Signs, Agreement, Thermo Fisher, Develop, CDx, Selpercatinib, LOXO-292
30. Sumitomo Dainippon and Roivant Signs a Memorandum of Understanding to Form $3B Alliance
Published: Sept 05, 2019 | Tags: Eli Lilly, Signs, Agreement, Thermo Fisher, Develop, CDx, Selpercatinib, LOXO-292
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com